![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | C07D 401/06 | (1974.07) |
C07D 401/14 | (1974.07) |
(11) | Patento numeris | 3710439 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 18879484.6 |
Europos patento paraiškos padavimo data | 2018-11-14 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-09-23 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-02-15 |
(46) | Apibrėžties vertimo paskelbimo data | 2023-05-10 |
(86) | Numeris | PCT/US2018/061060 |
Data | 2018-11-14 |
(87) | Numeris | WO 2019/099524 |
Data | 2019-05-23 |
(30) | Numeris | Data | Šalis |
201762586775 P | 2017-11-15 | US |
(72) |
BLAKE, James, F. , US
BURGESS, Laurence, E. , US
CHICARELLI, Mark, Joseph , US
CHRISTENSEN, James, Gail , US
COOK, Adam , US
FELL, Jay, Bradford , US
FISCHER, John, P. , US
MARX, Matthew, Arnold , US
MEJIA, Macedonio, J. , US
SAVECHENKOV, Pavel , US
VIGERS, Guy, P.A. , US
SMITH, Christopher, Ronald , US
RODRIGUEZ, Martha, E. , US
TANG, Tony Pisal , US
|
(73) |
Mirati Therapeutics, Inc. ,
9393 Towne Centre Drive
Suite 200, San Diego, CA 92121,
US
Array Biopharma Inc. , 3200 Walnut Street, Boulder, CO 80301, US |
(74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
(54) | KRas G12C inhibitoriai |
KRAS G12C INHIBITORS |
Mokėjimo data | Galiojimo metai | Suma | |
2024-10-04 | 7 | 162.00 EUR |
2025-11-14 |